Internal Medicine, Infectious Disease · Brooklyn, NY
NPI
1093919144
Since 2007
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
800 Poly Pl
Brooklyn, NY, 11209
Phone (718) 836-6600
Groups this clinician bills Medicare through
Medicare paid, 2024
$16K
152 services
Medicare patients, 2024
84
Average age 71
Drug cost, 2024
$3.1M
4,000 prescriptions
Company payments, 2025
$90.57
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul J Kelly was code 99233 (hospital e&m - subsequent), 47 times for 31 patients. In total Paul J Kelly billed 152 services in 8 codes, and Medicare paid $16K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-08-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 47 | 31 | $102.51 | $4,818 |
| 99223 Hospital E&M - Initial | Facility | 40 | 36 | $152.77 | $6,111 |
| 99214 Office E&M - Established | Facility | 37 | 18 | $69.24 | $2,562 |
| 99222 Hospital E&M - Initial | Facility | 11 | 11 | $115.60 | $1,272 |
By year: 2022 $19K for 189 services; 2023 $13K for 138 services; 2024 $16K for 152 services.
Medicare prescription drug claims, 2024
In 2024, the drug Paul J Kelly prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 315 prescriptions and refills. In total Paul J Kelly wrote 4,000 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 315 | 315 | 41 | $1.2M |
| Atorvastatin Calcium Generic | 263 | 390 | 51 | $1,526 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 172 | 201 | 32 | $5,897 |
| Gabapentin Generic | 126 | 142 | 21 | $1,408 |
| Lisinopril Generic | 125 | 185 | 22 | $483 |
| Omeprazole Generic | 117 | 147 | 19 | $1,165 |
| Amlodipine Besylate Generic | 100 | 162 | 21 | $414 |
| Juluca Dolutegravir/Rilpivirine | 83 | 83 | Under 11 | $275K |
| Prezcobix Darunavir/Cobicistat | 81 | 85 | Under 11 | $197K |
| Hydrochlorothiazide Generic | 71 | 109 | 12 | $151 |
| Pravastatin Sodium Generic | 61 | 67 | Under 11 | $397 |
| Tamsulosin Hcl Generic | 59 | 89 | 11 | $925 |
| Zolpidem Tartrate Generic | 57 | 57 | Under 11 | $221 |
| Quetiapine Fumarate Generic | 55 | 55 | Under 11 | $286 |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 55 | 57 | Under 11 | $255K |
Brand drugs: - claims; generic drugs: 2,639 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul J Kelly $90.57 ($90.57 in general payments such as food, travel and fees) from 2 companies. The largest payer was Gilead Sciences, Inc. with $69.98.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.